Global Interest Rate Hikes Loom, Israel Stands Alone with Cut

Major central banks, including the US Federal Reserve, are expected to raise interest rates significantly this week, a move largely priced into markets but with potential impact from the Fed's tone and future outlook. The US 10-year Treasury yield has surpassed 5%, a level not seen in two decades, indicating a shift in investor behavior and increased borrowing costs. Japan is also anticipated to raise its interest rate by a quarter percent on Friday, while the Bank of England is expected to do the same on Tuesday.

In stark contrast, Israel is preparing to lower its interest rate, a move attributed to its past favorable inflation data, low inflation, and a strong foreign exchange reserve position. This divergence from global trends is supported by factors like the relatively low increase in electricity prices compared to the West, partly due to natural gas discoveries. However, the article questions how long Israel can remain disconnected from global economic pressures, suggesting that sustained global rate hikes could eventually impact the Israeli economy, potentially leading to imported inflation.

The Tel Aviv Stock Exchange is expected to open with mixed trading. Asian markets are relatively calm, and futures appear stable. Teva Pharmaceutical Industries is noted as a strong performer, considered a defensive stock during turbulent times, with the broader pharmaceutical sector showing resilience.

The digest also touches upon the revolutionary impact of weight-loss injections, comparing their potential to save lives and healthcare systems to the AI revolution. Companies like Eli Lilly and Novo Nordisk are leading this trend, with significant growth potential still untapped despite the drugs being on the market for several years. The article briefly mentions specific stock movements on the Tel Aviv exchange, including declines in Doral and Nofar Energy and a surge in OptiMiT, while noting a drop in chip stocks and a rise in software companies.